Priya Balasubramanian, PhD

Priya Balasubramanian, PhD, is an experienced scientist with an extensive background in clinical and translational research. She is passionate about advancing research programs to rapidly bring new therapies to patients who need them most.

Dr. Balasubramanian obtained her doctorate degree from the University of Southern California, where she trained under Dr. Valter Longo, a world-renowned scientist in the field of aging biology. Her work in Laron Syndrome, or Growth Hormone Receptor Deficiency, led to the significant finding that individuals with this rare growth disorder are highly protected from cancer and diabetes. Collaborating with a team of experts in the growth hormone/IGF-1 field, she was able to further the research community’s understanding of the role of this pathway in human aging and disease including cancer, diabetes, obesity, and cardiovascular disease. Dr. Balasubramanian also led several research projects to translate these findings to the clinic.

In her most recent role at the Foundation for Prader-Willi Research, Dr. Balasubramanian managed several patient-focused clinical programs in Prader-Willi Syndrome, a rare neuro-developmental disorder. These programs include a clinical study to collect real-world data, building a clinical trial network to make trials more effective for sponsors, patients, and caregivers, and identifying drugs that can be repurposed to treat hyperphagia and obesity in Prader-Willi Syndrome.

Dr. Balasubramanian has extensive experience communicating with scientific, business, and lay audiences. She works on CURE Epilepsy’s Research Team to advance our research programs and initiatives while supporting research communications.